Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

News & Events
: IR Events

IR Events

Archived Events

Special Meeting of the Shareholders

New York, NY

Biotech Showcase 2020

Hilton San Francisco Union Square, San Francisco

Webcast

12th Annual LD Micro Main Event

Luxe Sunset Boulevard Hotel, Bel-Air, CA

Webcast

Benchmark’s 8th Annual Discovery 1x1 Conference

New York Athletic Club, New York City

Sidoti & Company Fall 2019 Investor Conference

Grand Hyatt, New York, NY

Webcast

Ladenburg Thalmann 2019 Healthcare Conference

Sofitel, New York, NY

Webcast

Fall Investor Summit 2019

JW Marriott Essex House, New York, NY

Webcast

2019 NAVREF Conference

San Antonio, Texas

BIO 2019 International Convention

Philadelphia, PA

Webcast

American Society of Clinical Psychopharmacology

Scottsdale, Arizona

Second Chance Digital Impact Recipient Gala

National Harbor, Maryland

2019 Annual Meeting of the Shareholders

The Offices of Lowenstein Sandler LLP at 1251 Avenue of the Americas, New York, New York 10020

Spring Investor Summit 2019

JW Marriott Essex House, New York, NY

Webcast

Sidoti & Company Spring 2019 Conference

Webcast

29th Annual Oppenheimer Healthcare Conference

Westin New York Grand Central, New York, NY

31st Annual ROTH Conference

The Ritz-Carlton, Laguna Niguel, Dana Point, CA

Webcast

21st Annual BIO CEO & Investor Conference

New York Marriott Marquis, New York, NY

Webcast